Concepedia

Intrathecal chemotherapy for management of steroid-refractory CAR T-cell–associated neurotoxicity syndrome

Nirav N. Shah, Bryon D. Johnson, Timothy S. Fenske, Renju Raj, Parameswaran Hari

Blood Advances · 2020 · 61 citations · 7 references

DOIFull text

Open access

Concepts

References

7

Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

Margherita Norelli, Barbara Camisa, Giulia Barbiera et al. · Nature Medicine · 2018 · 1.4K citations

, , +16

Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

Bianca Santomasso, Jae H. Park, Darin Salloum et al. · Cancer Discovery · 2018 · 924 citations · Full text

, , +17

Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells

Philipp Karschnia, Justin T. Jordan, Deborah Forst et al. · Blood · 2019 · 347 citations · Full text

, , +16

Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia

Noelle V. Frey, Pamela A. Shaw, Elizabeth O. Hexner et al. · Journal of Clinical Oncology · 2019 · 269 citations · Full text

, , +17

CAR T-Cell Associated Neurotoxicity: Mechanisms, Clinicopathologic Correlates, and Future Directions

Bradley D. Hunter, Caron A. Jacobson · JNCI Journal of the National Cancer Institute · 2019 · 197 citations · Full text

, , +17